Smokers, disadvantaged groups and people from non-English speaking backgrounds are among those less likely to access bowel cancer screening, research led by a UNSW PhD candidate has found.
Patients with hard-to-treat tumours could know within six months whether a cancer drug developed at UNSW is more effective than traditional chemotherapy, allowing them to live a relatively normal life during treatment.
Research assessing the impact of genomic testing on women with a high-risk of developing breast cancer has received backing in the latest round of funding from the Cancer Council NSW.
